BCG coverage and the annual risk of tuberculosis infection over a 14- year period in the Philippines assessed from the nationwide prevalence surveys

International Journal of Tuberculosis and Lung Disease

Volumn 4, Issue 3, 2000, Pages 216-222

  Tupasi, Thelma E ^a   Radhakrishna, S ^b   Pascual, M L ^a   Quelapio, M I D ^a   Villa, M L ^a   Co, V M ^a   Sarol, J ^c   Mangubat, N ^a   Reyes, A C ^a   Sarmiento, A ^d   Solon, M ^e   Solon, F ^e   Burton, L ^f   Lofranco, V S ^d   Rostrata, M P C ^d   Mantala, M J ^d  

^a MAKATI MEDICAL CENTER   (Philippines)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

^d DEPARTMENT OF HEALTH   (Philippines)

^e DOST Compound   (Philippines)

^f XAVIER UNIVERSITY   (Philippines)

Author keywords

Annual risk of TB infection (ARTI); BCG; Philippines; Prevalence survey; Tuberculin test

Indexed keywords

BCG VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BCG VACCINATION; CHILD; FEMALE; HUMAN; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PHILIPPINES; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; BCG VACCINE; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; PHILIPPINES; PREVALENCE; TUBERCULIN TEST; TUBERCULOSIS;

EID: 0034099238     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Sutherland I. Recent studies in the epidemiology of tuberculosis based on the risk of being infected with tubercle bacilli. Adv Tuberc Res 1976; 19: 1-63.
2. The National Institute of Tuberculosis. Report on a National Tuberculosis Prevalence Survey in the Republic of the Philippines (1981-1983). Manila, Philippines: The National Institute of Tuberculosis, 1984.
3. Tupasi T E, Radhakrishna S, Rivera A B, et al. The 1997 nationwide tuberculosis prevalence survey in the Philippines. Int J Tuberc Lung Dis 1999; 3: 471-477.
4. Tupasi T E, Radhakrishna S, Quelapio M I D. Tuberculosis in the urban poor settlements in the Philippines. Int J Tuberc Lung Dis 2000; 4: 4-11.
5. Arnadottir T, Rieder H L, Trébucq A, Waaler H T. Guideline for conducting tuberculin skin test surveys in high prevalence countries. Tubercle Lung Dis 1996; 77 (Suppl 1): 1-20.
6. Canetti G, Fox W, Khomenko A, et al. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Organ 1969; 41: 21-43.
7. Kwamanga D O, Swai O B, Agwanda R, Githui W. Effect of non-tuberculous mycobacterial infection on tuberculin results among primary school children in Kenya. East Afr Med J 1995; 72: 222-227.
8. Kim SJ, Yong Y P, Bai G H, Lee E K, Lew W J. Tuberculin PPD RT23: has it lost some of its potency? Int J Tuberc Lung Dis 1998; 2: 857-860.
9. Kim S J, Hong Y P, Bai G H, Lee E K, Lew W J. Rebuttal: The debate about the stability of PPD RT23 is not closed. Int J Tuberc Lung Dis 1998; 2: 795-796.
10. Haslov K, Ponce-de-Leon Rosales S, Rangel-Frausto S, Olesen Larsen S. Tuberculin PPD RT23: still going strong. Int J Tuberc Lung Dis 1998; 2: 793-796.
11. Arnadottir T, Parkkali L, Quinley J. Philippines national tuberculosis control program: external evaluation. WP/PHL/TUB/ 001/VD/92/RS/93/0024. Manila, Philippines: WHO Western Pacific Regional Office, 1993.
12. World Health Organization Global Tuberculosis Programme. WHO Report 1998. WHO/TB/98.237. Geneva, Switzerland: WHO, 1998.
13. The work of the World Health Organization in the Western Pacific Region. Report of the Regional Director. WPR/RC49/2. Manila, Philippines: WHO Western Pacific Regional Office, 1998.
14. Hong Y P, Kim S J, Lew W J, Lee E K, Han Y C. The seventh nationwide tuberculosis prevalence survey in Korea. Int J Tuberc Lung Dis 1995; 2: 27-36.